Sejelas

Experience matters, especially when it comes to building and investing in biotech. In this week’s Sejelas Ask the Experts interview, we feature Stephan Christgau, Founding Partner of Eir Ventures, who shares insights on: ✔️ How operational experience shapes investment strategy ✔️ The untapped potential of Nordic life sciences ✔️ The importance of cost-efficient drug development in Europe Stephan's journey highlights the intersection of science, strategy, and innovation in transforming patient care. Read the full interview here: https://lnkd.in/drqAUv9s #biotech #investments #nordics #eirventures

Do you know that there is significant medical potential in the medicinal use of plants, even in stigmatised areas like mental and sexual well-being? In this Sejelas Founder-CEO Interview series, we hear from John Boghossian, the Co-Founder and CEO at Kadence Bio. The London-based team is working on the first FDA-approved treatment for premature ejaculation, and a pipeline of compounds to target mood disorders. Read the full article here: https://lnkd.in/gTKfRmse #biotech #intimacy #mental #wellbeing #lifescience #entrepreneur #sejelas #founderceo #interviewseries

It’s not every day that you find a chartered accountant turned biotech entrepreneur. In this Sejelas Founder-CEO Interview series, we hear from Sharon Cunningham, the Co-Founder and CEO at Shorla Oncology. The Ireland-headquartered team is developing and commercialising innovative oncology drugs, focusing on indications where existing treatments are limited, in shortage or inadequate for the target population. Read the full article here: https://lnkd.in/gFW4-khS #biotech #repurposingdrugs #lifescience #entrepreneur #sejelas #founderceo #interviewseries

Do you know that most approved treatments in cardiology mainly address symptoms but do not regenerate damaged hearts? In this Sejelas CEO Interview series, we hear from Matthieu de Kalbermatten, the CEO at CellProthera SAS. The team is developing groundbreaking stem cell therapy to regenerate damaged heart tissue and is in Phase I/IIB clinical trial. Read the full article here: https://lnkd.in/gDPXpbsn #biotech #stemcell #therapy #lifescience #sejelas #ceointerviewseries

"With approximately 20 million new cancer cases globally each year, the urgency for personalised, effective treatment options is higher than ever." In this Sejelas Founder-CEO Interview series, we hear from Wahid Awad, Ph.D. MBA, the Founder and CEO at Rosetta Omics. The Paris-based team aims to revolutionise precision medicine, starting with cancer, by tumour characterisation via high-resolution proteomic profiling. Read the full article here: https://lnkd.in/gCXMs-Yj #biotech #multiomics #ML #AI #lifescience #sejelas #founderceo #interviewseries

Cancer is a moving target that constantly adapts to resist treatment and escape the immune system. There is a pressing demand for new precision medicine in oncology.   In this Sejelas CEO Interview series, we hear from Paul Bravetti, CEO of Brenus Pharma, where the team is developing innovative therapeutic vaccines (STC) to empower patients in their cancer treatment by restoring the immune system’s role as a sentinel. 🎉 Congratulations on their announcement of closing a €22M Series A funding round! Read the full article here: https://lnkd.in/gpsbBTNw #Immunotherapy #Oncology #CancerVaccine #PrecisionMedicine #Biotech #HealthcareInnovation #SeriesAFunding #CancerVaccine #STC #Sejelas #CEOinterviewseries

"At Teitur, our name captures the essence of our mission. Meaning “joyful” or “bright” in Old Norse, Teitur reflects our commitment to bringing light and hope to patients and families affected by Huntington’s and Parkinson’s diseases. " In this Sejelas Founder-CEO Interview series, we hear from Dr. Simon Mølgaard, the Co-Founder and CEO at Teitur Trophics. The Danish biotech team develops novel therapeutics for treating or preventing neurodegenerative diseases. Read the full article here: https://lnkd.in/gYxz45ZM #biotech #neuroscience #lifescience #sejelas #founderceo #interviewseries

"The most important part of our business cannot be taught, and that is experience." In this week's Ask the Experts Interview series, we hear from Casper Breum, an accomplished VC investor in the life science industry. He shares his experience in co-leading Sound Bioventures, a Copenhagen-based VC fund. For more insights, read the full article here: https://lnkd.in/g7QbkSXP #lifescience #therapeutics #venturecapital #investing #leadership #sejelas #asktheexperts #interviewseries

"Make a difference" and "Make things happen". In this week's Ask the Experts Interview series, we hear from Bo Rode Hansen, an accomplished leader in the global biotech and pharmaceutical industries. He shares his experience in leading cutting-edge organisations towards success. Read the full article here: https://lnkd.in/d_dKaNBW #biotech #pharmaceutical #lifescience #leadership #sejelas #asktheexperts #interviewseries

Do you know that cancer treatment is never a one-size-fits-all approach for patients? In this Sejelas Founder-CEO Interview series, we hear from Dr. Jana Fischer, the Co-Founder and CEO at Navignostics AG. The team specialises in spatial single-cell proteomic tumour analysis for better cancer treatment. Read the full article here: https://lnkd.in/gcbhATci #diagnostics #cancer #tumour #lifescience #sejelas #founderceo #interviewseries